Others have demonstrated significant correlation between platelet levels and concentration of PDGF-β (a driver of liver fibrosis), however, antiplatelet therapy did not affect PDGF-β levels despite exhibiting protective effects on liver fibrosis [19]. Here, PDGFB is linked to Hepatic fibrosis.